LMAT

LeMaitre Vascular, Inc. (LMAT)

Healthcare • Medical Instruments & Supplies

StockNasdaqGMUnited StatesUS5255582018

77.65 USD -2.07% today Updated 13 Nov 2026 09:32

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by LeMaitre Vascular, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 09:32. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 24 Feb 2027 in 103 days · 16:00 · estimate 0.73

Last results 0.65 vs 0.69 estimated 04 Nov 2026 · Miss -5.3%

Beat the estimate 8 of 12 3 missed · 1 in line

Average surprise +5.9% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
24 Feb 2027 16:00	0.73	—	—	Upcoming
04 Nov 2026 16:00	0.69	0.65	-5.3%	Miss
04 Aug 2026 16:00	0.81	0.74	-8.3%	Miss
05 May 2026 16:00	0.66	0.68	+3.0%	Beat
25 Feb 2026 16:00	0.66	0.68	+2.4%	Beat
06 Nov 2025 16:00	0.56	0.75	+33.1%	Beat
05 Aug 2025 16:00	0.57	0.60	+6.1%	Beat
01 May 2025 16:00	0.50	0.48	-3.6%	Miss
27 Feb 2025 16:00	0.49	0.49	-0.7%	In line
31 Oct 2024 16:00	0.43	0.49	+13.3%	Beat
01 Aug 2024 16:00	0.47	0.52	+10.3%	Beat
02 May 2024 16:00	0.39	0.44	+13.8%	Beat
27 Feb 2024 16:00	0.36	0.38	+7.0%	Beat
01 Nov 2023 16:00	0.30	0.33	+9.4%	Beat
01 Aug 2023 16:00	0.32	0.37	+16.2%	Beat
02 May 2023 16:00	0.25	0.27	+7.1%	Beat
23 Feb 2023 16:00	0.26	0.25	-2.3%	Miss
27 Oct 2022 16:00	0.28	0.25	-9.4%	Miss
28 Jul 2022 16:00	0.30	0.29	-4.4%	Miss
28 Apr 2022 16:00	0.28	0.27	-2.4%	Miss
24 Feb 2022 16:00	0.31	0.28	-8.7%	Miss
28 Oct 2021 16:00	0.33	0.30	-7.7%	Miss
29 Jul 2021 16:00	0.36	0.40	+11.7%	Beat
29 Apr 2021 16:00	0.27	0.28	+3.7%	Beat
25 Feb 2021 16:00	0.29	0.34	+18.1%	Beat
29 Oct 2020 16:00	0.19	0.35	+81.5%	Beat
23 Jul 2020 16:00	0.01	0.21	+3,118.9%	Beat
30 Apr 2020 16:00	0.16	0.16	+1.1%	Beat
06 Feb 2020 16:00	0.23	0.23	+0.7%	In line
23 Oct 2019 16:00	0.21	0.25	+21.4%	Beat
24 Jul 2019 16:00	0.21	0.23	+10.4%	Beat
01 May 2019 17:00	0.19	0.17	-9.7%	Miss
19 Feb 2019 16:00	0.19	0.19	+4.3%	Beat
04 Oct 2018 16:00	0.21	0.21	+1.0%	In line
26 Jul 2018 16:00	0.32	0.23	-26.7%	Miss
25 Apr 2018 16:00	0.21	0.19	-9.2%	Miss
21 Feb 2018 16:00	0.20	0.21	+5.1%	Beat
26 Oct 2017 16:00	0.20	0.25	+23.8%	Beat
27 Jul 2017 16:00	0.17	0.23	+35.2%	Beat
26 Apr 2017 16:00	0.13	0.16	+21.6%	Beat
21 Feb 2017 16:00	0.16	0.13	-16.1%	Miss
26 Oct 2016 16:00	0.15	0.17	+14.6%	Beat
27 Jul 2016 16:00	0.11	0.14	+27.3%	Beat
02 May 2016 16:00	0.10	0.11	+11.6%	Beat
24 Feb 2016 16:00	0.09	0.13	+42.5%	Beat
27 Oct 2015 16:00	0.08	0.11	+40.4%	Beat
28 Jul 2015 16:00	0.07	0.10	+46.4%	Beat
28 Apr 2015 16:00	0.05	0.08	+60.0%	Beat
25 Feb 2015 16:00	0.07	0.11	+62.5%	Beat
28 Oct 2014 16:00	0.05	0.05	+6.0%	Beat

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	249.6M	+13.5%	57.7M	23.1%	2.52	+30.6%	74.5M
2024	219.9M	+13.6%	44M	20.0%	1.93	+44.0%	37.2M
2023	193.5M	+19.7%	30.1M	15.6%	1.34	+44.1%	29.5M
2022	161.7M	—	20.6M	12.8%	0.93	—	22.1M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by day
Period	Opening price	High	Low	Closing price	Change	Volume
12 Nov 2026	79.41	79.76	77.46	77.65	-2.07%	166,300
11 Nov 2026	78.76	80.08	78.75	79.29	+0.34%	137,300
10 Nov 2026	80.58	80.73	78.58	79.02	-2.64%	293,300
09 Nov 2026	81.17	81.92	79.98	81.16	+0.33%	185,900
06 Nov 2026	81.98	82.59	79.93	80.89	-3.11%	326,400
05 Nov 2026	81.79	85.97	80.73	83.49	-5.04%	533,800
04 Nov 2026	82.44	89.23	81.95	87.92	+9.08%	520,200
03 Nov 2026	81.26	82.12	80.47	80.60	-0.81%	423,700
02 Nov 2026	82.06	82.39	80.80	81.26	+0.40%	270,700
30 Oct 2026	85.53	85.53	80.03	80.94	-5.08%	427,400
00 Mon 0000	157.29	236.48	315.67	394.86	+0.00%	000,000
00 Mon 0000	553.24	632.43	711.62	790.81	+0.00%	000,000
00 Mon 0000	49.19	128.38	207.57	286.76	+0.00%	000,000
1,249 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Does LeMaitre Vascular (LMAT) Trade At A Premium To Cash Flow? (opens in a new tab) Simply Wall St. · 08 Nov 2026 06:12
LeMaitre Vascular (LMAT) Shares Dropped, So What Is Driving Attention Now? (opens in a new tab) Simply Wall St. · 08 Nov 2026 05:17
Earnings Guidance Lift Might Change The Case For Investing In LeMaitre Vascular (LMAT) (opens in a new tab) Simply Wall St. · 08 Nov 2026 02:16
LeMaitre Vascular (LMAT) Acquires Vascular Assets To Expand Outside North America (opens in a new tab) Simply Wall St. · 07 Nov 2026 18:13
LeMaitre Vascular, Inc. (LMAT) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 07 Nov 2026 08:14
LeMaitre to Participate in Upcoming Investor Conferences (opens in a new tab) 06 Nov 2026 21:05
LeMaitre Vascular (LMAT) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 19:46
LeMaitre Vascular, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 13:30
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $86 (opens in a new tab) Benzinga · 05 Nov 2026 12:01
LeMaitre Vascular Inc (LMAT) (Q3 2026) Earnings Call Highlights: 12% Organic Growth, B. ... (opens in a new tab) GuruFocus.com · 05 Nov 2026 11:10
Citizens Maintains Market Outperform on LeMaitre Vascular, Lowers Price Target to $110 (opens in a new tab) Benzinga · 05 Nov 2026 10:11
LeMaitre Vascular Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 05 Nov 2026 03:14
LeMaitre Vascular (LMAT) Misses Q3 Earnings Estimates (opens in a new tab) Zacks · 04 Nov 2026 23:45
LeMaitre: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 22:39
LeMaitre’s (NASDAQ:LMAT) Q3 2026 sales beat estimates but stock drops 11.9% (opens in a new tab) StockStory · 04 Nov 2026 21:58

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 79.29 USD
Market cap: 1.8B
Dividend yield: 1.29%
5-year average yield: 0.88%
Payout ratio: 35%
Last dividend: 0.2500 USD · 19 Nov 2026
Next ex-dividend date: 19 Nov 2026
Exchange: NasdaqGM
Country: United States
Sector: Healthcare
Industry: Medical Instruments & Supplies
Currency: USD

Dividends

Ex-dividend date	Per share
20 Aug 2026	0.2500 USD
21 May 2026	0.2500 USD
12 Mar 2026	0.2500 USD
20 Nov 2025	0.2000 USD
00 Mon 0000	394.8600 USD
00 Mon 0000	474.0500 USD
8 older dividends: create a free account to see them

Why this score

How the score is made up
Part of the score	Points	Why
Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble.	5.4 / 25	Yield of 1.3% on today's price
Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover.	25.0 / 25	Dividend uses 32% of free cash flow (3-year average)
Dividend growth How many years in a row the dividend has risen, and how fast.	15.0 / 15	Dividend up 13 years in a row, 17.3% a year
Quality Return on equity, net margin and how stable the margins are.	10.5 / 15	ROE of 16%
Valuation Free cash flow yield and the P/E against its sector.	5.8 / 10	P/E 28.2 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price.	5.0 / 5	Analysts' target is +28% from the price

Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
Figure	Value	Reading	Sector median
P/E (trailing)	28.24×	Weak	30.56×
P/E (forward)	24.65×	Fair	14.16×
Price / book	4.11×	Weak	3.5×
Price / sales	6.6×	Weak	3.33×
EV / EBITDA	20.39×	Weak	11.19×
Free cash flow yield	2.4%	Fair	2.1%

Quality
Figure	Value	Reading	Sector median
Gross margin	70%	Good	54.9%
Operating margin	24.7%	Good	5.8%
Net margin	23.5%	Good	1.2%
Return on equity	15.6%	Good	4.4%
Return on assets	6.6%	Fair	2.7%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	15.6%	Good	10.1%
EPS growth / year	39.4%	Good	10.2%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	0.44×	Good	0.4×
Net debt / EBITDA	-2.6×	Good	1.46×
Interest cover	13.1×	Good	2.17×
Current ratio	14.6×	Good	2.64×

Dividends
Figure	Value	Reading	Sector median
Payout of earnings	34.6%	Good	0%
Payout of free cash flow	42.1%	Good	28.7%
Payout of free cash flow (3 years)	31.8%	Good	—
Dividend growth / year	17.3%	Good	6.5%
Years of rising dividends	13	Good	1.5

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow LMAT and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in